Table 3. Comparison between COPD patients who improved after pulmonary rehabilitation and those who did not, in terms of pre- and post-pulmonary rehabilitation exercise performance on an incremental exercise test and the six-minute walk test.a .
Variable | Post- PR improvers | Post- PR non-improvers | ||
---|---|---|---|---|
(n = 16) | (n = 6) | |||
Pre-PR | Post-PR | Pre-PR | Post-PR | |
Peak incremental exercise values | ||||
Workload | ||||
W | 36 ± 22 | 46 ± 17* | 27 ± 18 | 21 ± 13† |
% of the predicted value | 24.8 ± 14.3 | 34.2 ± 10.3* | 19.1 ± 12 | 15.1 ± 9.6 |
VO2, L/min | 0.76 ± 0.18 | 0.77 ± 0.21 | 0.70 ± 0.19 | 0.60 ± 0.15 |
VCO2, L/min | 0.81 ± 0.23 | 0.80 ± 0.25 | 0.69 ± 0.20 | 0.53 ± 0.12† |
VE, L/min | 33.7 ± 8.1 | 33.7 ± 9.7 | 30.4 ± 3.6 | 24.3 ± 4.1* |
VE/MVV ratio, % | 87.9 ± 18.6 | 87.0 ± 21.2 | 89.1 ± 25.7 | 72.8 ± 28.3* |
VT, L | 1.08 ± 0.34 | 1.09 ± 0.37 | 0.92 ± 0.20 | 0.76 ± 0.14† |
RR, breaths/min | 32 ± 6 | 30 ± 6 | 30 ± 3 | 30 ± 4 |
TI, s | 0.79 ± 0.19 | 0.81 ± 0.18 | 0.86 ± 0.18 | 0.83 ± 0.21 |
TE, s | 1.24 ± 0.27 | 1.27 ± 0.31 | 1.25 ± 0.15 | 1.22 ± 0.19 |
TI/Ttot ratio | 0.39 ± 0.04 | 0.39 ± 0.05 | 0.39 ± 0.05 | 0.39 ± 0.06 |
SpO2, % | 93 ± 2 | 94 ± 2 | 92 ± 2 | 92 ± 1 |
Post-6MWT values | ||||
6MWD | ||||
m, median (range) | 310 (170-425) | 338 (230-490)* | 285 (190-340) | 290 (230-466) |
% of the predicted value | 29.8 ± 7.2 | 34.5 ± 7.7* | 25.7 ± 5.0 | 30.2 ± 8.7 |
Borg dyspnea score, median (range) | 3 (0-5) | 3 (0.5-5) | 3.5 (2-5) | 3 (2-9) |
Borg leg fatigue score, median (range) | 2 (0-5) | 1 (0-5) | 1.75 (0-4) | 1.5 (0-7) |
SpO2, % | 92 ± 3 | 90 ± 4* | 92 ± 1 | 88 ± 2 |
PR: pulmonary rehabilitation; VO2: oxygen consumption; VCO2: carbon dioxide production; VE: minute ventilation; MVV: maximal voluntary ventilation; VT: tidal volume; RR: respiratory rate; TI: inspiratory time, TE: expiratory time; Ttot: total respiratory time; 6MWT: six-minute walk test; and 6MWD: six-minute walk distance. aValues expressed as mean ± SD, except where otherwise indicated. *p < 0.05 vs. pre-PR value. †p < 0.05 vs. post-PR improvers.